Literature DB >> 30963415

A case of acute kidney injury secondary to black cherry concentrate in a patient with chronic kidney disease secondary to type 2 diabetes mellitus.

Mohamad Matout1, Alex S Halme2, Jeffrey Wiseman2.   

Abstract

There are many herbal products which are accessible to patients, and they may provide with many health benefits. Nevertheless, some of these supplements can lead to significant morbidity as they can also have important side effects and impact patient's organ systems. In this case report, we present a patient with chronic kidney disease secondary to type II diabetes mellitus who develops acute kidney injury and metabolic disturbances secondary to consuming black cherry concentrate as a mean to self-manage his gout flare. The most likely mechanism of injury was cyclooxygenase inhibition by anthocyanins, molecular compounds found in cherries that have a similar mechanism of action to nonsteroidal anti-inflammatory medications. Patient's kidney injury and metabolic disturbances improved after the discontinuation of black cherry concentrate. This is the second case report that presents a correlation between consumption of cherry concentrate in a patient with chronic kidney disease and acute kidney injury.

Entities:  

Keywords:  Acute kidney injury; Anthocyanins; Chronic kidney disease; Herbal medicine

Mesh:

Substances:

Year:  2019        PMID: 30963415      PMCID: PMC6620216          DOI: 10.1007/s13730-019-00396-2

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  15 in total

1.  Immunohistochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the human fetal and adult male reproductive tracts.

Authors:  A Kirschenbaum; D R Liotta; S Yao; X H Liu; A P Klausner; P Unger; E Shapiro; I Leav; A C Levine
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

2.  Plant polyphenols in cancer and heart disease: implications as nutritional antioxidants.

Authors:  G G Duthie; S J Duthie; J A Kyle
Journal:  Nutr Res Rev       Date:  2000-06       Impact factor: 7.800

Review 3.  Cherries and health: a review.

Authors:  Letitia M McCune; Chieri Kubota; Nicole R Stendell-Hollis; Cynthia A Thomson
Journal:  Crit Rev Food Sci Nutr       Date:  2011-01       Impact factor: 11.176

Review 4.  Dietary flavonols: chemistry, food content, and metabolism.

Authors:  S Aisling Aherne; Nora M O'Brien
Journal:  Nutrition       Date:  2002-01       Impact factor: 4.008

Review 5.  NSAIDs: behind the mechanisms of action.

Authors:  F C Tulunay
Journal:  Funct Neurol       Date:  2000

6.  Cherry consumption and decreased risk of recurrent gout attacks.

Authors:  Yuqing Zhang; Tuhina Neogi; Clara Chen; Christine Chaisson; David J Hunter; Hyon K Choi
Journal:  Arthritis Rheum       Date:  2012-12

7.  2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

Authors:  Dinesh Khanna; Puja P Khanna; John D Fitzgerald; Manjit K Singh; Sangmee Bae; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

8.  Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries.

Authors:  N P Seeram; R A Momin; M G Nair; L D Bourquin
Journal:  Phytomedicine       Date:  2001-09       Impact factor: 5.340

9.  Consumption of cherries lowers plasma urate in healthy women.

Authors:  Robert A Jacob; Giovanna M Spinozzi; Vicky A Simon; Darshan S Kelley; Ronald L Prior; Betty Hess-Pierce; Adel A Kader
Journal:  J Nutr       Date:  2003-06       Impact factor: 4.798

10.  Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study.

Authors:  Francesco Lapi; Laurent Azoulay; Hui Yin; Sharon J Nessim; Samy Suissa
Journal:  BMJ       Date:  2013-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.